News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Pfizer shares are recommended to be trimmed rather than bought after a Hold downgrade.
  • Pfizer yields 6.2% but current price assumes materially stronger 2029 profits not yet supported by fundamentals.
  • Advisers recommend a disciplined mid-term profit-taking trade with defined entry, target, and stop.
  • Treasure Global’s subsidiary will build a 1,000-acre, 360 MW AI-enabled solar farm in Malaysia.
  • The US$367 million project includes a 25-year power supply agreement for a data center.
  • The development is projected to generate about US$7.3 million in annual technology revenue and expands the firm's renewable footprint.

Latest Articles

Fed Inspector General Flags Gaps in Protections for Sensitive Economic Information

Fed Inspector General Flags Gaps in Protections for Sensitive Economic Information

The Federal Reserve's internal watchdog found that the central bank's protections for proprietary economic information are insufficient, citing weaknesses in risk identification, insider controls, training and information sharing. The Office of Inspector General urged the Board to adopt nine recommendations to better define critical assets and eval…

Aptorum Group Provides Update on DiamiR Biosciences Merger

Aptorum Group Provides Update on DiamiR Biosciences Merger

Aptorum Group Limited (NASDAQ: APM) announced an anticipated merger with DiamiR Biosciences Corp. to form Niki BioSolutions, Inc., which will trade on NASDAQ under the ticker symbol 'NIKI' post-merger expected to close in July 2026. The company will undergo a 1-for-10 reverse stock split and redomesticate to Delaware to maintain NASDAQ listing comp…

Buy Tyler on the Dip: Public-Sector SaaS That AI Can't Replace (Yet)

Buy Tyler on the Dip: Public-Sector SaaS That AI Can't Replace (Yet)

Tyler Technologies is down big from its 2025 highs, but the business — mission-critical software for local governments — is structurally defensive and cash generative. This trade targets a rebound tied to cloud conversion progress, continued recurring revenue growth, and margin expansion as on-prem customers migrate. Entry, stop and target are laid…

Standard Nuclear Allocates Majority of IPO to Ten Largest Investors

Standard Nuclear Allocates Majority of IPO to Ten Largest Investors

Standard Nuclear Inc. assigned roughly 65% of the shares in its initial public offering to its 10 largest investors, with demand reportedly multiple times the reduced quantity of shares available. The company sold 10 million Class A shares at $15 apiece, raising $150 million, and the stock is scheduled to begin trading on the New York Stock Exchang…

Nike at a Crossroads: Turnaround Potential vs. Lingering Risks

Nike at a Crossroads: Turnaround Potential vs. Lingering Risks

Nike shares sit roughly 45% below their 52-week high, leaving investors split between seeing a deep-value turnaround and a stock that still faces material operational headwinds. A one-time $986 million IEEPA tariff recovery lifted reported Q4 FY2026 EPS to $0.72, while underlying EPS was $0.20. Key questions hinge on China demand, the pace of margi…

Piper Sandler Starts SpaceX Coverage at Neutral, Flags Near-Term Constraints

Piper Sandler Starts SpaceX Coverage at Neutral, Flags Near-Term Constraints

Piper Sandler opened coverage of SpaceX with a Neutral rating and a $156 price target, signaling confidence in the company’s multi-year potential but pointing to immediate headwinds that could restrict upside. The firm highlighted staged lockup expirations, uncertainty about a potential acquisition by Tesla, and large capital expenditure requiremen…

Goldman Posts Eye-Popping Q2 EPS Beat, Tops Big-Bank Peers on Triple Strength

Goldman Posts Eye-Popping Q2 EPS Beat, Tops Big-Bank Peers on Triple Strength

Goldman Sachs delivered a striking Q2 2026 performance, reporting EPS of $20.98 versus a $14.38 consensus and revenue of $20.34 billion against a $16.12 billion estimate. All six of the largest U.S. banks beat both EPS and revenue, but Goldman’s outperformance was the most pronounced, driven by a surge in investment banking fees, elevated trading r…

Market movers: Micron, AMD slide as select names rally across caps

Market movers: Micron, AMD slide as select names rally across caps

Equity markets displayed disparate performance across market-cap segments, with several large-cap technology and industrial names retreating and a handful of mid- and small-cap equities posting significant gains. Micron and AMD were among the larger decliners after company-specific developments were reported, while shares of several smaller compani…

Lucid Shares Jump After CEO Denies Bankruptcy, Cites Adequate Liquidity

Lucid Shares Jump After CEO Denies Bankruptcy, Cites Adequate Liquidity

Lucid Group Inc. rallied more than 10% in morning trading after CEO Silvio Napoli publicly refuted reports that the luxury electric vehicle maker was considering bankruptcy or a take-private deal. An SEC 8-K confirmed AlixPartners was hired to advise on operational improvement only, while analysts remain split on the company’s capital outlook. Inve…

Broadcom's AI Moat Keeps Expanding — A Tactical Long on AVGO

Broadcom's AI Moat Keeps Expanding — A Tactical Long on AVGO

Broadcom is riding a widening AI infrastructure moat driven by hyperscaler custom chips, networking, and a growing software franchise. With a $1.82T market cap, strong free cash flow and an Apple commitment that reduces concentration risk, AVGO looks like a tactical buy into a mid-term rebound. This idea lays out an entry at $381.78, a stop at $350…